Unicycive Therapeutics News - UNCY

Company Name	Stock Ticker Symbol	Market	Type
Unicycive Therapeutics Inc	UNCY	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.00	0.00%	0.97	08:38:29

Open Price	Low Price	High Price	Close Price	Prev Close
				0.97

more quote information »

Recent News

Date	Time	Source	Heading
4/25/2024	8:52	IHNW	FeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
4/10/2024	07:03	GLOBE	Unicycive Therapeutics to Present at the Noble Capital..
3/28/2024	16:15	GLOBE	Unicycive Therapeutics Announces Full Year 2023 Financial..
3/25/2024	07:03	GLOBE	Unicycive Therapeutics to be Featured in Multiple..
3/14/2024	07:03	GLOBE	Unicycive Announces $50 Million Private Placement
3/13/2024	07:03	GLOBE	Unicycive Therapeutics Delivers Both an Oral and Poster..
3/07/2024	16:12	GLOBE	Unicycive Therapeutics Completes Enrollment in Pivotal..
3/04/2024	07:03	GLOBE	Unicycive Therapeutics Announces Orphan Drug Designation..
2/21/2024	16:06	EDGAR2	Form 8-K - Current report
2/14/2024	07:03	GLOBE	Unicycive Therapeutics to Present Two Posters on..
1/29/2024	07:03	GLOBE	Unicycive Therapeutics Announces Both an Oral and Poster..
1/23/2024	07:03	GLOBE	Unicycive Therapeutics Issues Shareholder Letter to..
1/22/2024	16:27	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
12/18/2023	07:03	GLOBE	Unicycive Therapeutics Announces Enrollment of First Patient..
12/08/2023	16:36	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
11/29/2023	07:03	GLOBE	Unicycive Therapeutics to Participate in Two Investor..
11/14/2023	16:20	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/14/2023	16:15	GLOBE	Unicycive Announces Third Quarter 2023 Financial Results and..
10/23/2023	11:12	EDGAR2	Form 8-K - Current report
10/23/2023	07:03	GLOBE	Unicycive Therapeutics Reaches Alignment with the FDA on..
9/25/2023	16:05	EDGAR2	Form 8-K - Current report
9/07/2023	16:33	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/07/2023	16:05	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
9/06/2023	09:16	EDGAR2	Form 8-K - Current report
9/06/2023	07:03	GLOBE	Unicycive Therapeutics Strengthens Board of Directors with..
8/31/2023	16:16	EDGAR2	Form 8-K - Current report
8/30/2023	16:47	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/30/2023	16:47	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/30/2023	16:45	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/29/2023	07:03	GLOBE	Unicycive Therapeutics Featured on Nasdaq Amplify Issuer..
8/14/2023	17:36	GLOBE	Unicycive Announces Second Quarter 2023 Financial Results..
8/14/2023	17:12	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
7/31/2023	16:15	EDGAR2	Form 8-K - Current report
7/26/2023	06:05	EDGAR2	Form 8-K - Current report
7/20/2023	07:03	GLOBE	Unicycive Therapeutics to Participate in the H.C. Wainwright..
7/18/2023	07:03	GLOBE	Unicycive Therapeutics Announces Publication of Positive..
7/14/2023	16:30	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
7/13/2023	19:33	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/13/2023	19:01	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/13/2023	18:10	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
6/29/2023	17:04	GLOBE	Unicycive Therapeutics Provides Regulatory Update on..
6/16/2023	07:38	GLOBE	Unicycive to Participate in the Healthcare Virtual..
5/16/2023	08:29	GLOBE	Unicycive Announces First Quarter 2023 Financial Results and..